This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignee: Pfizer Vaccines, Lcc. Active years: 2014-2016.
Location History:
- San Diego, CA (US) (2014)
- Del Mar, CA (US) (2016)
Company Filing History:
Years Active: 2014-2016
Title: David Robert Stead: Innovator in Immunology
Introduction
David Robert Stead is a notable inventor based in Del Mar, CA (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of 2 patents, his work focuses on innovative solutions for IgE-mediated disorders.
Latest Patents
David's latest patents include the IgE CH3 peptide vaccine. This invention relates to the provision of novel immunogens comprising an antigenic IgE peptide, preferably linked to an immunogenic carrier. The compositions comprising these immunogens aim for the prevention, treatment, or alleviation of IgE-mediated disorders. Furthermore, the invention details methods for the production of these medicaments, immunogenic compositions, and their use in medicine.
Career Highlights
David Robert Stead is currently associated with Pfizer Vaccines, LLC, where he continues to advance his research and development efforts. His work at Pfizer has positioned him as a key player in the field of vaccine innovation.
Collaborations
Throughout his career, David has collaborated with notable colleagues, including Brian Robert Champion and Paul Andrew Wright. These collaborations have further enriched his research and contributed to the success of his inventions.
Conclusion
David Robert Stead's contributions to immunology through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments and therapies in the field.